Patent Assignment
Reel/Frame 047882/0088
Assignment of Assignor's Interest
Recorded: 2019-01-02
Pages: 11
Assignors
GRAY, NATHANAEL S.
Executed: 2018-12-11
ZHANG, TINGHU
Executed: 2018-12-11
OLSON, CALLA M.
Executed: 2018-12-10
LIANG, YANKE
Executed: 2018-12-05
KWIATKOWSKI, NICHOLAS
Executed: 2018-12-11
Assignee
DANA-FARBER CANCER INSTITUTE, INC.
450 BROOKLINE AVENUE, BOSTON, MASSACHUSETTS, 02215
Covered Property
(1)
Degradation of Cyclin-Dependent Kinase 9 (CDK9) by Conjugation of CDK9 Inhibitors with E3 Ligase Ligand and Methods of Use
Patent:
10,532,103 →
Application:
16/094,102 →
Publication:
US 2019/0111143
PCT:
PCT/US2017/028924 ↗
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.